tiprankstipranks
GridAI Technologies (GRDX)
NASDAQ:GRDX
US Market

GridAI Technologies (GRDX) Price & Analysis

1,320 Followers

GRDX Stock Chart & Stats

$3.79
$0.14(4.65%)
At close: 4:00 PM EDT
$3.79
$0.14(4.65%)

GridAI Technologies News

GRDX FAQ

What was GridAI Technologies’s price range in the past 12 months?
GridAI Technologies lowest stock price was $1.65 and its highest was $6.93 in the past 12 months.
    What is GridAI Technologies’s market cap?
    GridAI Technologies’s market cap is $23.30M.
      When is GridAI Technologies’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were GridAI Technologies’s earnings last quarter?
      GridAI Technologies released its earnings results on Aug 13, 2019. The company reported -$525 earnings per share for the quarter, missing the consensus estimate of N/A by -$525.
        Is GridAI Technologies overvalued?
        According to Wall Street analysts GridAI Technologies’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does GridAI Technologies pay dividends?
          GridAI Technologies does not currently pay dividends.
          What is GridAI Technologies’s EPS estimate?
          GridAI Technologies’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does GridAI Technologies have?
          GridAI Technologies has 7,081,123 shares outstanding.
            What happened to GridAI Technologies’s price movement after its last earnings report?
            GridAI Technologies reported an EPS of -$525 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
              Which hedge fund is a major shareholder of GridAI Technologies?
              Currently, no hedge funds are holding shares in GRDX
              What is the TipRanks Smart Score and how is it calculated?
              Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                Company Description

                GridAI Technologies

                GridAI Technologies Corp. functions as a clinical-stage biopharmaceutical enterprise primarily dedicated to developing precise, locally-acting treatments for various digestive system ailments. Its core activity involves researching and advancing therapeutic solutions specifically designed for patients with gastrointestinal diseases. The company's pipeline features several key drug candidates, including Latiglutenase, Capeserod, Adrulipase, and Niclosamide. GridAI Technologies was established on January 30, 2014, and maintains its principal offices in Boca Raton, Florida.

                GridAI Technologies (GRDX) Earnings & Revenues

                Ownership Overview

                11.09%0.52%1.08%86.23%
                11.09% Insiders
                1.08% Other Institutional Investors
                86.23% Public Companies and
                Individual Investors
                Popular Stocks